These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 30830574)
1. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources. Pladevall-Vila M; Pottegård A; Schink T; Reutfors J; Morros R; Poblador-Plou B; Timmer A; Forns J; Hellfritzsch M; Reinders T; Hägg D; Giner-Soriano M; Prados-Torres A; Cainzos-Achirica M; Hallas J; Brandt L; Cortés J; Aguado J; Perlemuter G; Falissard B; Castellsagué J; Jacquot E; Deltour N; Perez-Gutthann S CNS Drugs; 2019 Apr; 33(4):383-395. PubMed ID: 30830574 [TBL] [Abstract][Full Text] [Related]
2. Agomelatine versus other antidepressive agents for major depression. Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008851. PubMed ID: 24343836 [TBL] [Abstract][Full Text] [Related]
3. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database. Billioti de Gage S; Collin C; Le-Tri T; Pariente A; Bégaud B; Verdoux H; Dray-Spira R; Zureik M CNS Drugs; 2018 Jul; 32(7):673-684. PubMed ID: 29959758 [TBL] [Abstract][Full Text] [Related]
4. Agomelatine: new drug. Adverse effects and no proven efficacy. Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators. Forns J; Pottegård A; Reinders T; Poblador-Plou B; Morros R; Brandt L; Cainzos-Achirica M; Hellfritzsch M; Schink T; Prados-Torres A; Giner-Soriano M; Hägg D; Hallas J; Cortés J; Jacquot E; Deltour N; Perez-Gutthann S; Pladevall M; Reutfors J J Affect Disord; 2019 Apr; 249():242-252. PubMed ID: 30780117 [TBL] [Abstract][Full Text] [Related]
6. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123 [TBL] [Abstract][Full Text] [Related]
7. Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark. Ishtiak-Ahmed K; Musliner KL; Christensen KS; Mortensen EL; Nierenberg AA; Gasse C Am J Psychiatry; 2024 Jan; 181(1):47-56. PubMed ID: 37849303 [TBL] [Abstract][Full Text] [Related]
8. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials. Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920 [TBL] [Abstract][Full Text] [Related]
9. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control. Kasper S; Corruble E; Hale A; Lemoine P; Montgomery SA; Quera-Salva MA Int Clin Psychopharmacol; 2013 Jan; 28(1):12-9. PubMed ID: 23023074 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251 [TBL] [Abstract][Full Text] [Related]
11. Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies. Llorca PM; Lançon C; Brignone M; Rive B; Salah S; Ereshefsky L; Francois C Curr Med Res Opin; 2014 Dec; 30(12):2589-606. PubMed ID: 25249164 [TBL] [Abstract][Full Text] [Related]
12. Paroxetine versus other anti-depressive agents for depression. Purgato M; Papola D; Gastaldon C; Trespidi C; Magni LR; Rizzo C; Furukawa TA; Watanabe N; Cipriani A; Barbui C Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006531. PubMed ID: 24696195 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response. Papakostas GI; Nielsen RZ; Dragheim M; Tonnoir B J Psychiatr Res; 2018 Jun; 101():72-79. PubMed ID: 29554497 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of agomelatine in previously-treated depressed patients. Kasper S; Hajak G Eur Neuropsychopharmacol; 2013 Aug; 23(8):814-21. PubMed ID: 23820051 [TBL] [Abstract][Full Text] [Related]
15. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]
16. Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2-year long-term nation-wide population-based study emulating a randomized trial. Kessing LV; Ziersen SC; Andersen FM; Gerds T; Budtz-Jørgensen E Acta Psychiatr Scand; 2024 May; 149(5):378-388. PubMed ID: 38379028 [TBL] [Abstract][Full Text] [Related]
17. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder. Khandker RK; Kruzikas DT; McLaughlin TP J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572 [TBL] [Abstract][Full Text] [Related]
18. The effects of agomelatine on sexual function in depressed patients and healthy volunteers. Montejo A; Majadas S; Rizvi SJ; Kennedy SH Hum Psychopharmacol; 2011 Dec; 26(8):537-42. PubMed ID: 22102540 [TBL] [Abstract][Full Text] [Related]
19. Duloxetine versus other anti-depressive agents for depression. Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006533. PubMed ID: 23076926 [TBL] [Abstract][Full Text] [Related]
20. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]